These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5553720)

  • 1. A study of tumor allograft-sensitized lymph nodes in mice. I. Biologic activities of transferred cells and antibody titers of donor and recipient mice.
    Irvin GL; Eustace JC
    J Immunol; 1971 Apr; 106(4):956-61. PubMed ID: 5553720
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of tumor allograft sensitized lymph nodes in mice. II. In vitro immunoglobulin synthesis, immunofluorescence and morphology.
    Irvin GL; Eustace JC; McAleer JA; Levi DF
    J Immunol; 1972 Jan; 108(1):207-13. PubMed ID: 4551576
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of actinomycin D and puromycin on the in vitro cytotoxic activity of lymphocytes.
    Brondz BD
    Transplant Proc; 1969 Mar; 1(1):416-9. PubMed ID: 5406833
    [No Abstract]   [Full Text] [Related]  

  • 4. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
    Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
    Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell transfer studies on the persistence of homograft sensitivity in the mouse: in vitro and in vivo correlates of the activity of sensitised lymph node cells.
    Warren J; Gowland G
    J Pathol; 1974 Oct; 114(2):101-11. PubMed ID: 4613807
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 7. Allograft stimulated immunoglobulin synthesis by regional node cells.
    Irvin GL; Eustace JC; Lipton JS
    Surg Forum; 1969; 20():267-8. PubMed ID: 4192213
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia L 1210 homograft in Swiss mice: immunologic, cellular and chemotherapeutic responses.
    Prince HN; Grunberg E
    J Immunol; 1969 Aug; 103(2):324-33. PubMed ID: 5803789
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies bound to the lymph node cells. I. Separation of the antibodies.
    Fujii G; Hirose Y; Goto S; Ishibashi Y
    Jpn J Exp Med; 1971 Aug; 41(4):291-8. PubMed ID: 4936580
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on antibody formation of thymus cells, lymph node cells and spleen cells. I. Alterations in cell counts and antibody titers in media after incubation of thymus cells, lymph node cells and mixtures of these cells.
    Yamasaki A
    Hiroshima J Med Sci; 1967 Dec; 16(3):191-201. PubMed ID: 5602851
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
    Warnatz H
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on antibody formation of thymus cells, lymph node cells and spleen cells. II. Alterations in the number of antibody producing cells and serum antibody titers following primary immunization.
    Yamasaki A
    Hiroshima J Med Sci; 1967 Dec; 16(3):203-13. PubMed ID: 5602852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skin and transplant reaction in mice to the introduction of lymphoid cells of a donor sensitized with inducing microbial antigens].
    Ogurtsov RP; Zubzhitskiĭ IuN
    Vestn Akad Med Nauk SSSR; 1971; 26(1):22-5. PubMed ID: 4928208
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoreactions in leukaemias with respect to immunotherapeutic trials (author's transl)].
    Libánský J
    Cas Lek Cesk; 1974 Feb; 113(5):141-5. PubMed ID: 4434427
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor immunity in vivo: use of the 125 IUdR prelabeling technique to monitor cell death in immune animals.
    Forman J; Ketchel MM; Hofer KG
    Transplantation; 1972 Aug; 14(2):166-74. PubMed ID: 5068223
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells.
    Watanabe T; Yagi Y; Pressman D
    J Immunol; 1971 May; 106(5):1213-21. PubMed ID: 5574404
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Mar; 64(3):579-85. PubMed ID: 6986497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor inhibition by means of sensitized regional lymph nodes.
    Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
    Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.